RxDoctor Payments Data

Catherine Pihoker

Pediatric Endocrinology · Seattle, WANPI 1013098375

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $94 of the $126 with a category attached, or 74.4%. 5 manufacturers reported payments, led by Novo Nordisk at 25.6% of the total. That places this record below the midpoint for pediatric endocrinology clinicians in WA, where the typical reported total is $461.

$126in general payments, 2019–2025

Across 5 payments — averaging $25.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$32
  • Insulet Corporation$25
  • BETA Bionics, Inc.$24
  • Abbott$23
  • Amphastar Pharmaceuticals, Inc.$22
$1,737,367in research payments, 2019–2025

Across 59 payments — averaging $29,447 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$1.7M

What the payments were for

  • Food & beverage$9474%
  • Education$3226%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$126 in reported general payments places this provider in the 25th percentile of 29 pediatric endocrinology providers in Washington.

See all pediatric endocrinology providers in Washington

Other pediatric endocrinology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →